Dr. Nimmi Kapoor

Dr. Nimmi Kapoor

Honors & Awards

  • Alpha Omega Alpha, Cornell Medical School
  • Summa Cum Laude graduation honors, UCLA
  • Phi Beta Kappa, Departmental Highest Honors, UCLA
  • Lynn Sage Breast Cancer Achievement Award (x2)
  • Outstanding Scientific Presentation Award–ASBrS
  • Oncology Trainee Travel Award ASCO
  • Louis Gibofsky Memorial Prize for Research

Research & Committee Membership

  • Editorial Board Member, World Journal of Clinical Oncology
  • Editorial Board Member, SM Surgery Journal (SMSJ)
  • Research Committee Member, American Society of Breast Surgeons (ASBrS)
  • Continuing Medical Education subcommittee Member, ASBrS
  • SWOG Member

Breast-Related Publications

  1. Kapoor NS, Banks KC. Should multi-gene panel testing replace limited BRCA1/2 testing?: A review of genetic testing for hereditary breast and ovarian cancers. World J Surg Proc. 2015 In Press.
  2. Kapoor NS, Curcio LD, Blakemore C, Bremner A, McFarland R, West JG, Banks KC.  Multi-gene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Onc 2015; 22: 3282-3288. 
  3. Kapoor NS, Shamonki J, Sim MS, Chung CT, Giuliano AE. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive Breast Cancer. Ann Surg Oncol. 2013; 20:2576-81.
  4. West JG, Kapoor NS, Liao SY, Chen JW, Bailey L, Nagourney RA. Multifocal breast cancer in young women with prolonged contact between their breasts and their cellular phones. Case Rep Med. 2013;2013:354682. doi: 10.1155/2013/354682
  5. Kapoor NS, Eaton A, King TA, Stempel SM, Patil SM, Morris EA, Brogi E, Morrow M. Should breast density influence patient selection for breast conserving surgery? Ann Surg Oncol. 2013; 20:600-6.
  6. Kapoor NS, Sim MS, Lin J, Giuliano AE. Long-term Outcome of Patients Managed With Sentinel Lymph Node Biopsy Alone for Node-Negative Invasive Breast Cancer. Arch Surg. 2012;147:1047-52.
  7. Kapoor NS, Chung A, Huynh K, Giuliano AE. Preliminary Results: Double Lumpectomies for Multicentric Breast Carcinoma. Am Surgeon. 2012. 78:1345-8.
  8. Jensen JA, Lin JH, Kapoor NS, Giuliano AE. Surgical delay of the nipple-areolar complex: a powerful technique to maximize nipple viability following nipple-sparing mastectomy. Ann Surg Oncol. 2012 Oct;19(10):3171-6.
  9. (Kapoor NS)/Arora N, King TA, Jacks LM, Stempel SM, Patil SM, Morris EA, Morrow M. The impact of density on the presenting features of malignancy. Ann Surg Oncol. 2010; 3:211-218
  10. (Kapoor NS)/Arora N, Martins D, Ruggerio D, Tousimis E, Swistel AJ, Osborne MP, Simmons RM. Effectiveness of a noninvasive digital infrared thermal imaging system in the detection of breast cancer. Am J Surg 2008; 196:523-6
  11. (Kapoor NS)/Arora N, Martins D, Huston TL, Christos P, Hoda S, Osborne MP, Swistel AJ, Tousimis E, Pressman PI, Simmons RM. Sentinel node positivity rates with and without frozen section for breast cancer. Ann Surg Oncol 2008 15:256-61
  12. (Kapoor NS)/Arora N, Hill C, Hoda SA, Rosenblatt R, Pigalarga R, Tousimis EA. Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancy. Am J Surg 2007 194: 444-9
  13. (Kapoor NS)/Arora N, Simmons RM. Paget disease of the breast. Kuerer’s Breast Surgical Oncology. 2010. 19: 209-214.
  14. (Kapoor NS)/Arora N, Simmons RM. Malignant breast disease: diagnosis and assessment. General Surgery: Principles and International Practice. 2nd ed. 2008. 14: 285-292
  15. Umoh, EM, (Kapoor NS)/Arora N, Simmons RM. Skin, nipple, and areola-sparing mastectomy. Breast Cancer On-Line. http://www.bco.org. 2008. 11(12)

Thyroid-Related & Other Publications

  1. (Kapoor NS)/Arora N, Scognamiglio T, Lubitz CC, Zhu B, Moo TA, Kato MA, Zarnegar R, Chen YT, Fahey TJ III. Identification of borderline thyroid tumors by gene expression array analysis. Cancer 2009; 115: 5421-31
  2. (Kapoor NS)/Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey TJ III. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 2009; 19: 473-7
  3. (Kapoor NS)/Arora N, Scognamiglio T, Wagner PL, Goldsmith SJ, Zarnegar R, Fahey TJ III. Extrathyroidal extension is not all equal: implications of macroscopic vs. microscopic extent in papillary thyroid carcinoma. Surgery 2008; 144:942-7
  4. Wagner PL, Moo TA, (Kapoor NS)/Arora N, Liu YF, Zarnegar R, Scognamiglio T, Fahey TJ III. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Ann Surg Oncol. 2008; 15:2833-41
  5. (Kapoor NS)/Arora N, Zhu B, Scognamiglio T, Fahey TJ III. Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg. 2008; 32:1237-46
  6. (Kapoor NS)/Arora N, Dhar P, Fahey TJ III. Local and regional anesthesia for thyroid surgery. J Surg Oncol. 2006 94(8): 708-13
  7. Finley DJ, (Kapoor NS)/Arora N, Zhu B, Gallagher L, Fahey TJ III. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab. 2004 89(7): 3214-23
  8. Kapoor NS, Hernandez A, Barie PS. Chronic pelvic osteomyelitis. Surgical Infections. 2012; 2:132-3.
  9. Kapoor NS, O’Neill JP, Katabi N, Wong RJ, Shah JP. Kimura’s Disease: Diagnostic Challenges and Clinical Management. Am J Otolaryngol. 2012; 2:259-62.
  10. Kreisel D, (Kapoor NS)/Arora N, Weisenberg SA, Saqi A, Krupnick AS, Demetriades AM, Iakovou C, Conetta R, Lee PC. Tuberculosis presenting as an endobronchial mass. J Thorac Cardiovasc Surg. 2007;133:582-4
  11. Kapoor, NS. Terrorism, Media, and Hate Crimes. Box 7-2 in Terrorism and Public Health. 2nd ed. Editors Bary Levy, MD, MPH and Victor Sidel, MD, MPH. 2011.
  12. Kapoor, NS. Anger, Racism, and Hate Crimes. Box 6-2 in Terrorism and Public Health. Editors Bary Levy, MD, MPH and Victor Sidel, MD, MPH. 2004. 204-205.

Posters & Presentations

  1. Kapoor NS, Swisher J, McFarland R, et al. Impact of hereditary multigene panel testing for cancer survivors.  American Society of Clinical Oncology Cancer Survivorship Symposium – Upcoming Poster January 2016.
  2. Kapoor NS, Curcio LD, Patrick M, et al. Multi-gene panel testing and the cancers identified in patients at risk for hereditary breast cancer. San Antonio Breast Cancer Symposium— Poster Discussion 2015.
  3. Link J, Buck L, Kapoor NS. The breast cancer index as a tool in decision making for adjuvant hormonal therapy in early luminal breast cancer: Initiation, withdrawal, and continuance. San Antonio Breast Cancer Symposium—Poster 2015.
  4. Kapoor NS, Curcio LD, Blakemore C, et al.  Benefits and safety of multi-gene panel testing. American Society of Clinical Oncology Breast Cancer Symposium—Poster 2015.
  5. Kapoor NS, Curcio LD, Bremner AK, Banks KC, West JG. Multi-Gene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer. American Society of Breast Surgeons. Oral Presentation 2015
  6. Kapoor NS, Shamonki J, Yoon J, Chung C, Giuliano AE. Is there a need for sentinel lymph node biopsy in microinvasive breast cancer? American Society of Clinical Oncology—Poster 2012
  7. Kapoor NS, Yoon J, Shamonki J, Giuliano AE. Predictors of variability between primary breast cancers and ipsilateral breast tumor recurrences. Society of Surgical Oncology— Poster 2012
  8. Kapoor NS, Yoon J, Giuliano AE. Survival and recurrence patterns of patients with tumor-free sentinel lymph nodes in long-term follow-up. Pacific Coast Surgical Association. Oral Presentation 2012
  9. Kapoor NS, Yoon J, Fahey TJ III, Michelassi FM. Fifty years of general surgery training: trends in career choices and satisfaction of graduates from a single academic institution. Academic Surgical Congress. Oral Presentation 2012
  10. Kapoor NS, Yoon J, Shamonki J, Giuliano AE. Predictors of variability between primary breast cancers and ipsilateral breast tumor recurrences. American College of Surgeons—Southern California Chapter— Oral presentation 2012
  11. Kapoor NS, Chung A, Huynh K, Giuliano AE. Preliminary Results: Double Lumpectomies for Multicentric Breast Carcinoma. American College of Surgeons—Southern California Chapter—Oral presentation 2012
  12. Kapoor NS, Eaton A, King TA, et al. Should breast density influence patient selection for breast conserving surgery? American College of Surgeons, NY Chapter—presentation 2011
  13. Kapoor NS, Eaton A, King TA, et al. Should breast density influence patient selection for breast conserving surgery? Society of Surgical Oncology—poster 2011
  14. Arora N, King TA, Jacks LM, et al. The impact of breast density on the presenting features of malignancy. American Society of Breast Surgeons— presentation 2010
  15. Arora N, Turbendian HK, Scognamiglio T, et al. Extrathyroidal extension is not all equal: implications of macroscopic vs. microscopic extent in papillary thyroid carcinoma. American Association of Endocrine Surgeons—presentation 2008
  16. Arora N, Effectiveness of a noninvasive digital infrared thermal imaging system in the detection of breast cancer. American Society of Breast Surgeons—poster 2008
  17. Arora N, Scognamiglio T, Zhu B, Fahey TJ III. Molecular Characterization of Pathologically Indeterminate Thyroid Tumors. American College of Surgeons—presentation at Surgical Forum 2007
  18. Arora N, Martins D, Huston TL, et al. Sentinel node positivity rates with and without frozen section for breast cancer. Society of Surgical Oncology—poster 2007
  19. Arora N, Martins D, Christos P, et al. Sentinel node positivity rates with and without frozen section for breast cancer. New York Surgical Society—presentation 2007
  20. Arora N, Bellemare S, Gaglio P, et al. Fate of livers nobody wants. American Transplant Congress – poster 2004

Fellowships

  • Breast Fellowship, John Wayne Cancer Institute
  • Research Fellowship, New York Presbyterian Hospital-Cornell

Residency

  • Breast Surgical Oncology Memorial Sloan-Kettering Cancer Center
  • General Surgery New York Presbyterian Hospital - Cornell

Medical School

  • Weill Cornell Medical College -Graduated with honors in research. - Alpha Omega Alpha

Undergraduate

  • University of California, Los Angeles (summa cum laude)
Dr. Nimmi Kapoor
Practice Type: 
Surgical Oncology

Doctor Tabs

View Other Members of Your Team

Dr. Nimmi Kapoor

Nimmi S. Kapoor, MD, is a fellowship-trained, board-certified oncology surgeon specializing in breast and thyroid cancer, and is the Medical Director of Breastlink at the Encino Breast Care Center. 

Dr. Gary Dosik

Gary Dosik, M.D., is board-certified in Internal Medicine, Hematology and Medical Oncology. He has served San Fernando Valley patients for more than 30 years and has received extensive training in oncology and hematology.

Dr. Johnny Chang

Johnny Chang, M.D., is a board certified hematologist-oncologist. Dr. Chang has advanced sub-specialty training and an extensive background in cancer research. He has worked with the Hematology Oncology Medical Group of San Fernando Valley since 2004.

Dr. Stanley Rossman

Stanley Rossman, M.D., is an experienced physician with board certifications in internal medicine, hematology and oncology. He has more than 35 years of experience treating patients in San Fernando Valley, working with the local medical community in a variety of roles.

Dr. Mark Goldstein

Mark Goldstein, M.D., has served southern California patients since completing fellowship training at LAC+USC Medical Center more than 30 years ago. He is board-certified in internal medicine, hematology and oncology.

Dr. Julie Huynh

Julie Huynh, M.D., is a hematologist-oncologist with board-certification in internal medicine, hematology, and medical oncology. Dr. Huynh completed her fellowship in hematology and medical oncology at Harbor-UCLA Medical Center in Torrance, California. While at Harbor-UCLA Medical Center, Dr. Huynh served as chief fellow.